This Web page has been archived on the Web.
2006 November Report of the Auditor General of Canada
November 2006 Report—Chapter 8
Exhibit 8.6—Funding trends for the three programs audited ($ millions)
|
Product Safety |
2003–04 |
2004–05 |
2005–06 |
|---|---|---|---|
|
Core funding |
8.1 |
9.9 |
7.3 |
|
Revenue authorized to be respent (fees for services) |
0 |
0 |
0 |
|
Special initiatives |
10.3 |
10.3 |
10.4 |
|
Reallocations (funds taken from or given to a program) |
(0.6) |
(1.5) |
0.5 |
|
Total |
17.8 |
18.7 |
18.2 |
|
Drug Products Program |
2003–04 |
2004–05 |
2005–06 |
|---|---|---|---|
|
Core funding |
7.1 |
7.1 |
4.8 |
|
Revenue authorized to be respent (fees for services) |
28.6 |
28.6 |
28.6 |
|
Special initiatives |
17.1 |
18.3 |
21.3 |
|
Reallocations (funds taken from or given to a program) |
(1.0) |
(3.4) |
(3.9) |
|
Total |
51.8 |
50.6 |
50.8 |
|
Medical Devices Program |
2003–04 |
2004–05 |
2005–06 |
|---|---|---|---|
|
Core funding |
2.0 |
1.1 |
1.0 |
|
Revenue authorized to be respent (fees for services) |
7.6 |
7.6 |
7.6 |
|
Special initiatives |
3.4 |
4.0 |
4.7 |
|
Reallocations (funds taken from or given to a program) |
(4.2) |
(1.3) |
0.4 |
|
Total |
8.8 |
11.4 |
13.7 |
Source: Health Canada (unaudited)